Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Expression and putative functions of melatonin receptors in malignant cells and tissues
1Institute of Environmental Health, Centre for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria, cem.ekmekcioglu@meduniwien.ac.at.
Abstract:
Melatonin, the popular hormone of the darkness, is primarily synthesized in the pineal gland, and acts classically through the G-protein coupled plasma membrane melatonin receptors MT1 and MT2, respectively. Although some of the receptor mediated functions of melatonin, especially those on the (central) circadian system, have been more or less clarified, the functional meaning of MT-receptors in various peripheral organs are still not sufficiently investigated yet. There is, however, accumulating evidence for oncostatic effects of melatonin with both, antioxidative and MT-receptor mediated mechanisms possibly playing a role. This review briefly summarizes the physiology of melatonin and MT-receptors, and discusses the expression and function of MT-receptors in human cancer cells and tissues.
Insights
Melatonin, a hormone synthesized in the pineal gland, influences circadian rhythms. Its receptors (MT1 and MT2) are increasingly linked to oncostatic effects in human cancers, warranting further investigation.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Melatonin is synthesized in the pineal gland and acts via MT1 and MT2 receptors.
- Melatonin's role in the central circadian system is understood, but its peripheral functions are less clear.
- Emerging evidence suggests melatonin has oncostatic (cancer-inhibiting) effects.
Purpose of the Study:
- To review the physiology of melatonin and its receptors.
- To discuss the expression and function of MT-receptors in human cancer cells and tissues.
- To explore potential mechanisms of melatonin's oncostatic action.
Main Methods:
- Literature review of melatonin physiology and MT-receptor function.
- Analysis of studies on MT-receptor expression in human cancers.
- Synthesis of evidence for melatonin's role in cancer.
Main Results:
- Melatonin physiology and MT-receptor signaling are summarized.
- MT-receptor expression is documented in various human cancer cells and tissues.
- Both antioxidative and MT-receptor mediated pathways may contribute to melatonin's oncostatic effects.
Conclusions:
- MT-receptors play a role in peripheral organs, including cancer.
- Melatonin's oncostatic effects in cancer are supported by accumulating evidence.
- Further research into MT-receptor function in human cancers is warranted.
Related Concept Videos
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Management of Insomnia

